Clinuvel Pharmaceuticals LimitedASX: CUV

CLINUVEL's injectable peptide platform

· Issued by Clinuvel Pharmaceuticals Limited via ASX

Filed with ASX ·

On 6ix: 6ix.com/news/clinuvels-injectable-peptide-platform

Watch Clinuvel Pharmaceuticals' latest callClinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call · Replay · Aug 27Read the transcript of Clinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call

A S X A N N O U N C E M E N T ASX : CUV | Nasdaq : CUVL | Börse Frankfurt: UR9 ASX Announcement P A G E 1 O F 2 CLINUVEL’s injectable peptide platform VLRX-L platform candidate being refined following pre-clinical data Executive Summary 1. CLINUVEL...

View Attachment

6ix hasn’t read this filing yet.

Clinuvel Pharmaceuticals Limited on 6ix

Earlier from Clinuvel Pharmaceuticals

Later from Clinuvel Pharmaceuticals

All Clinuvel Pharmaceuticals news releases